ANNUAL REPORT 2007 | 2008 - Gimv
ANNUAL REPORT 2007 | 2008 - Gimv
ANNUAL REPORT 2007 | 2008 - Gimv
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
19. GOODWILL IMPAIRMENT<br />
The goodwill recorded in the books relates solely to the buy-out<br />
companies. This goodwill is tested annually for impairment by<br />
comparing the carrying value of the subsidiaries in question with<br />
their fair value. In <strong>2007</strong>-<strong>2008</strong> this produced a total impairment<br />
loss of EUR 7 308.<br />
20. FINANCIAL ASSETS AT FAIR VALUE THROUGH<br />
PROFIT AND LOSS (IN EUR 000)<br />
The fi nancial assets, consisting of shareholdings by <strong>Gimv</strong> and<br />
its subsidiaries, reduced by EUR 42 313.<br />
In the <strong>2007</strong>-<strong>2008</strong> fi nancial year, the <strong>Gimv</strong> group invested<br />
EUR 123 319 in shareholdings. The main investments were VAG<br />
Armaturen and Rollinvest NV (Corporate Investment Belgium),<br />
the Halder-<strong>Gimv</strong> Germany Fund (Corporate Investment<br />
Germany), Metris and Telenet Group Holding (ICT) and Ablynx<br />
and Ambit Biosciences (Life Sciences).<br />
Divestments totalling EUR 212 199 were also undertaken. The<br />
main divestments were: Lyceum Capital, Alfacam, Jensen and<br />
Dujardin Foods (Corporate Investment Belgium), the Halder-<br />
<strong>Gimv</strong> Germany Fund (Corporate Investment Germany), Holowell<br />
(Corporate Investment Netherlands), Telenet Group Holding and<br />
Business Architects (ICT) and deVGen (Life Sciences).<br />
Unrealized capital gains amounted to EUR 34 644. These gains<br />
refl ect the periodical valuation exercises covering the entire portfolio.<br />
<strong>Gimv</strong> group values listed shareholdings at their bid price<br />
and unlisted shareholdings based on the valuation methods<br />
most appropriate for the particular type of investment, in line<br />
with the European Private Equity and Venture Capital Valuation<br />
Guidelines.<br />
<strong>2007</strong>-<strong>2008</strong> 2006-<strong>2007</strong><br />
1. Opening balance 690 811 557 477<br />
1.1. Investments 123 319 131 421<br />
1.2. Acquisition through business combination -<br />
1.3. Divestments (-) -212 199 -134 048<br />
1.4. Disposal of subsidiaries -<br />
1.5. Unrealized change (increase (+), decrease (-) in fair value) 34 644 135 441<br />
1.6. Increase (decrease) translation differences -<br />
1.7. Other (increase (+), decrease (-)) 11 823 520<br />
2. Closing balance<br />
Of which<br />
648 398 690 811<br />
Shares - listed 122 651 247 598<br />
Shares - unlisted 525 747 443 213<br />
Change in fair value recognised in profi t & loss during the period 34 644 135 441<br />
Estimated using a valuation technique 81 222 72 299<br />
Determined directly -50 794 63 142<br />
21. LOANS TO INVESTEE COMPANIES<br />
(IN EUR 000)<br />
Loans totalling EUR 49 811 were made, the largest being to<br />
Metris, Mondi Foods NV, Rollinvest NV, Verhaeren NV, VAG<br />
Armaturen, Fortress Warehousing & Distribution and Impression<br />
International. Loans totalling EUR 15 606 were repaid, with<br />
the largest repayments coming from Alfacam NV, Fortress<br />
Warehousing & Distribution, Mondi Foods NV, BAI Beheer<br />
and Elixent. The impact of valuation movements and transfers<br />
amounted to – EUR 19 944.<br />
| 135